Pet Food Composition Modulating Phosphorus and Enzyme Levels
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current pet food compositions do not effectively modulate phosphorus, alkaline phosphatase, and gamma-glutamyltransferase levels in companion animals, leading to potential nutritional deficiencies and health issues such as hypophosphatemia and organ calcification.
Innovation Solution
A pet food composition comprising protein, carbohydrates, fat, and specific metabolites that correlate with phosphorus, alkaline phosphatase, and gamma-glutamyltransferase levels, allowing for controlled dietary adjustments to increase or decrease these enzymes, thereby enhancing nutritional benefits and reducing production costs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional pet food compositions are used, then production costs are reduced, but phosphorus and enzyme levels cannot be effectively modulated, leading to nutritional deficiencies and health issues
Solution Approach 1:
The patent changes the chemical parameters of the pet food by incorporating specific metabolites (such as phosphorus-binding compounds, enzyme-modulating compounds) to alter phosphorus and enzyme levels. This allows precise modulation of nutritional parameters without requiring complete reformulation of the base diet, thus improving nutritional reliability while controlling production costs.
Solution Approach 2:
The patent uses metabolites as intermediary substances that mediate between the base pet food composition and the target phosphorus/enzyme levels. These metabolites act as active agents that bind phosphorus or modulate enzyme activity, providing a controlled mechanism to achieve desired nutritional outcomes without directly modifying the entire food matrix.
2Reliability
If metabolites are added to modulate phosphorus and enzyme levels, then nutritional benefits are enhanced, but production costs increase
Solution Approach 1:
The patent applies partial action by incorporating metabolites at specific, optimized levels rather than throughout the entire formulation. This allows achieving the desired phosphorus modulation effect with minimal metabolite inclusion, thereby enhancing nutritional reliability while limiting the increase in production costs to only what is necessary for efficacy.
3Reliability
If metabolites are added to modulate phosphorus and enzyme levels, then nutritional benefits are enhanced, but device complexity increases
Solution Approach 1:
The patent employs metabolites that can simultaneously modulate multiple parameters (phosphorus binding, enzyme activity, and potentially other nutritional parameters) through a single additive component. This multi-functionality reduces formulation complexity compared to using separate additives for each parameter, as one metabolite can address multiple nutritional concerns at once.
Data Source
AI summary
A specific type of organ health marker in a companion animal can be improved by adjusting the diet of the animal to increase the amount of a compound which positively or negatively modulates the specific type of organ health marker or adjusting the diet of the animal to decrease the amount of a compound which positively or negatively modulates the specific type of organ health marker. The specific type of organ health marker can be one or more of phosphorus, alkaline phosphatase, aspartate aminotransferase, or gamma-glutamyltransferase.